Abstract The "chemical obesogen" hypothesis conjectures that synthetic, environmental contaminants are contributing to the global epidemic of obesity. In fact, intentional food additives (e.g., artificial sweeteners and colors, emulsifiers) and unintentional compounds (e.g., bisphenol A, pesticides) are largely unstudied in regard to their effects on overall metabolic homeostasis. With that said, many of these contaminants have been found to dysregulate endocrine function, insulin signaling, and/or adipocyte function. Although momentum for the chemical obesogen hypothesis is growing, supportive, evidence-based research is lacking. In order to identify noxious synthetic compounds in the environment out of the thousands of chemicals that are currently in use, tools and models from toxicology should be adopted (e.g., functional high throughput screening methods, zebrafishbased assays). Finally, mechanistic insight into obesogeninduced effects will be helpful in elucidating their role in the obesity epidemic as well as preventing and reversing their effects.
Introduction
Since the industrial revolution, the goals of food technology have predominately been maximizing palatability, optimizing process efficiency, increasing shelf life, reducing cost, and improving food safety (free from harmful viruses, bacteria, and fungi). As such, over 4000 novel ingredients have entered the food supply, some intentionally (such as preservatives) and some inadvertently (such as bisphenol A, BPA), and there are 1500 new compounds that enter the market every year [1] . While food processing techniques are also constantly being optimized to minimize toxic compounds and toxicants such as lead, melamine, and aflatoxin, other "non-toxic" additives are not thoroughly tested for their chronic, additive, and/or cumulative effects on human physiology.
Obesity and related chronic disorders are increasing at alarming rates and it is estimated that 86 % of Americans will be overweight by 2030 [2] . This trend continues despite increases in awareness, nutritional and behavioral research, the amount of diet foods available, and even gym memberships [3] . Unfortunately, the etiology of obesity and diabetes in regard to biochemical mechanisms is still largely not understood. Treatment and prevention of obesity hinges on our ability to 1) characterize the biochemical pathways that promote obesity, 2) identify what changes in our environment are promoting obesity, and 3) avoid and reverse the effects of the offensive agents and practices. It is crucial that clinicians understand and communicate that most novel food ingredients have not been evaluated for metabolic safety. In this review, we outline what agents have been identified that may be contributing to obesity, describe current methods being used to identify offensive compounds, and identify critical gaps in our methods and body of knowledge.
The Importance of Identifying Agents that Contribute to Obesity
There is an abundance of research related to obesity etiology and prevention in regard to decreasing caloric intake and increasing energy expenditure. However, "non-traditional" risk factors are under increased scrutiny for their contributions to the obesity epidemic: emotional stress, sleep deprivation, disruption of normal circadian rhythm, composition of the gut microbiome, oxidative stress, medications such as antidepressants and oral contraceptives, average home temperature, and environmental toxicants [4••, 5•, 6] . Agents in our food supply have immense potential to affect metabolism due to continuous exposure and potential interactions among multiple compounds. A recently hypothesized factor contributing to the obesity epidemic is our exposure to obesogens, chemicals in our environment that can disrupt metabolism and lead to accumulation of excess fat mass (coined by Grün and Blumberg in 2006 [7] ). It is critical that we identify these obesogens in our food supply in order to facilitate obesity prevention and treatment [8••] .
Unfortunately, many of the obesogenic compounds in our food supply were added deliberately to enhance production instead of being added to enhance nutrition. For example, pesticides are added to ward off insects during farming; BPA is a strong, clear plastic that has ideal properties for making bottles and coating cans; and mono-and diglycerides are added to emulsify the fat and water in foods to achieve a favorable texture. Simple exclusion of these compounds may not be possible until alternatives are developed, but then these novel compounds must be tested. Like pharmaceuticals, thorough testing is timeconsuming and expensive.
Obesogen identification and characterization is in its infancy, and much of the scientific evidence supporting the relationship between synthetic compounds and the obesity epidemic is currently weak. Strong, evidence-based scientific support is derived from randomized, controlled trials, ideally cross-over design, that comprise four steps: 1) addition of the compound of interest, 2) observation of an effect, 3) removal of the compound of interest, and 4) disappearance of the effect. However, the bulk of evidence relating environmental contaminants and obesity is derived from epidemiological studies which are correlational by nature. While correlations are important, they are limited in that conclusions about causal relationships are impossible. Well-designed animal studies provide strong evidence within the animal model, but must be confirmed in humans. Cell studies are important for deriving mechanisms that may link certain compounds to obesity, yet provide only weak evidence for the global phenomenon (the obesity epidemic). Thus, we currently do not have any strong evidence that any contaminant, food additive, or ingredient that is "generally recognized as safe" (GRAS) causes obesity, which is essential for making confident recommendations and changes in public policy.
It is important to note that in evaluating foods for their contribution to obesity, we may identify ingredients that prevent obesity. For example, some hydrocolloids including guar gum and β-glucan may be able to increase satiety and reduce caloric intake with their bulking properties [9] . Also, anthocyanins (potent color compounds from grapes, purple corn, blueberries, and other plants) may reduce oxidative stress, prevent obesity, and help control diabetes in cell culture, animal models, and humans [10] . Again, not all compounds in a class are equal; for example, although the hydrocolloid guar gum may prevent obesity (mentioned above), another hydrocolloid called carrageenan, found commonly in chocolate milk and ice cream, may contribute to insulin resistance in mice [11] .
What in our Food is Making us Fat?
There are many aspects of the average Western diet that may promote obesity. The macronutrient ratio (fat:carbohydrate:protein), the characteristics of the fat (e.g., diets rich in palmitic acid vs. eicosapentaenoic acid), the characteristics of the carbohydrates (refined vs. whole grain carbohydrates) [12, 13] , and form of the protein [14] are major concerns and reviewed elsewhere [12] [13] [14] [15] [16] [17] . In addition, advances in food processing have facilitated consumption of high-caloric foods that are low in other nutrients (e.g., edible oils, refined grains) [15] as well as increased the glycemic load of common meals [16] . Increased consumption of nutrientpoor added fat, added sugar, added salt, and refined grains may also underlie obesity and co-morbidities in ways that extend beyond energy balance [17] . Baillie-Hamilton announced a well-received hypothesis in 2002 highlighting the potential for environmental compounds in our food to contribute to the obesity epidemic [6] . While the relationship between obesity and food structure is reviewed elsewhere [13] [14] [15] [16] [17] , herein, we will focus on potential obesogens and obesity-promoting food additives in our foods supply (Table 1) .
Fat: Saturated Fat and Trans-fat
The negative social stigma around saturated fat stems from studies correlating high intake of saturated fat, often from meat and cheese, with elevated risk of unhealthy weight gain, cardiovascular disease, insulin resistance and type 2 diabetes [12] . However, more comprehensive studies have revealed that this nutritional advice is oversimplified and misleading; lauric acid (C12:0) and stearic acid (C18:0) may not be as harmful as myristic acid (C14:0) and palmitic acid (C16:0) in regard to cardiovascular health [12] . Moreover, saturated [19, 20] High fructose corn syrup and sucrose soda, candy, breakfast cereal, granola/ nutrition bars; about 37 g/12 oz. soda
Despite popular reproach, the metabolic fate of high fructose corn syrup is similar to that of sucrose, yet the taste, convenience, and low cost of products with high fructose corn syrup may encourage excessive intake.
[21]
Micronutrients Salt processed foods May be indirectly related to obesity because of increased fluid consumption, including consumption of sugarsweetened beverages.
[22]
Ingredients that incidentally contain bioactive compounds Soy vegetarian meat substitutes, tofu; up to 50 mg soy isoflavones/serving
Although isoflavones bind the estrogen receptor, they may protect against obesity. Effects may be gender and age dependent.
[23]
Food additives and ingredients "generally recognized as safe" (GRAS; added purposefully) Mono-oleoylglycerol (MOG) as an emulsifier in ice cream, whipped toppings, margarine, shortening, 0.1-1.0 % Can also be formed in the gut from triglycerides by hydrolysis of fatty acids at sn-1 and sn-3 positions. Can stimulate GLP-1 secretion from L intestinal cells [24] and insulin secretion from rat islets [25] . [24, 25] Sodium benzoate (preservative) soda, salad dressing, fruit juices and jams, margarine; <0.1 % Can decrease leptin release in vitro. [26] Sodium sulfite (preservative) wine; up to 6 mM (750 mg/L) Can reduce leptin release and potentiate lipopolysaccharide-induced interleukin-6 secretion in vitro. [26, 27] highest quantity in meat, lower quantities in animal products; up to 3 ng/g in salmon
The U.S. EPA set a maximum daily dose of 7 μg/kg body weight. Some compounds in this class are endocrine disrupting compounds, carcinogens, and disruptors of development and nerve function. [50] medium chain fatty acids such as caproic acid (C6:0), caprylic acid (C8:0), and capric acid (C10:0) may even promote fat oxidation [64] . The science of macronutrient intake is very complex; replacement of saturated fat with other nutrient categories (e.g., monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), high vs. low glycemic index carbohydrates) often yields disparate results due to a variety of confounding factors (e.g., age, lifestyle factors) [12] . Thus, although we know that there are some aspects and some types of saturated fat that promote obesity, particularly in rodents, it is not appropriate to view all saturated fat as metabolically similar in humans.
Trans-fat, although inherent in bovine milk at about 0.85 g/kg and other natural foods, is consumed in much larger quantities from partially hydrogenated vegetable oil [18] . Partial hydrogenation of oil yields a solid (often soft and spreadable) fat at room temperature. It is a common ingredient in fried foods, high-fat bakery products (especially packaged cookies and cakes), and packaged frozen foods such as pizza and breaded chicken nuggets. Based on a meta-analysis of Prenatal lead exposure and exposure in childhood may interfere with signaling in the hypothalamic-pituitary-adrenal axis.
[57]
Other Alkylphenols (e.g., nonylphenol (NP), butylphenol BP)) bottled water, eggs, milk, up to 465 ng/L Intakes estimated at about 7.5 μg NP/day in Germans [58] One use for alkylphenols is as a precursor to detergents. They are endocrine disruptors that perpetuate estrogenic effects. There are regulated by the European Union but not yet by the U.S. [58, 59] Hormones given to animals milk; there are no more hormones in milk from cows treated with hormones than cows without treated with hormones
Recombinant bovine growth hormone (GH), or recombinant bovine somatotropin, increases the efficiency of milk production. Substantial evidence shows that bovine GH does not affect the composition of the milk. In fact, bovine GH is not active in humans, even when directly injected into the system. [60, 61] Antibiotics given to animals unknown Antibiotics are administered to farm animals to prevent disease and also to promote growth. Antibiotics can contaminate the environment and could potentially promote growth in humans. Additionally, meat and animal products can possess antibiotic-resistance strains of bacteria. [62, 63] four prospective cohort studies, an increase of 2 % energy from trans-fats (i.e., 5 g in a 2000 kcal diet) is associated with an increase in the risk of coronary heart disease by 23 % [18] . In the same vein, there is strong evidence that trans-fat consumption is associated with increased adiposity in monkeys [19] yet randomized, controlled clinical trials in humans have not been performed.
Food Additives and Ingredients "Generally Recognized as Safe" (GRAS)
The FDA maintains a database with "Everything added to food in the U.S." (EAFUS) [1] . As of January 2014, the database includes 3968 additives with varying regulatory statuses. Some of these ingredients are food additives approved by the FDA and others are GRAS (i.e., they have demonstrated safety through long-term use in the food supply and/or published studies). While many ingredients have undergone an extensive literature search for toxicology information, most of the items on this list have not been evaluated for effects on metabolic regulation. Artificial sweeteners, preservatives, monosodium glutamate (MSG), mono-oleoylglycerol (MOG) and others have demonstrated potential lipid accumulation effects (see Table 1 ). There are scores of other compounds that are used generously in our food but have not been evaluated for effects on key metabolic pathways (Table 2) . High intensity sweeteners are studied most often when comparing consumption of sugar-sweetened beverages to consumption of beverages with calorie-free (or low calorie) artificial sugars with the assumption that artificial sugars are inert. However, Kyriazis et al. demonstrated that saccharin can potentiate glucose-stimulated insulin release from isolated pancreatic β-cells via direct binding to the sweet taste receptor [65] . Additionally, aspartame, in combination with MSG, promoted fat accumulation and other pre-diabetic symptoms in C57BL/6 mice [66] . On the other hand, the high intensity sweetener stevia has the potential to treat insulin resistance in mice [67] . Recently, artificial sweeteners have been shown to resist breakdown during sewage treatment, thus persisting in the water system [68] . Formidably, irradiation of acesulfame (sold as acesulfame potassium, AceK) by sunlight can cause a persistent by-product that is greater than 500 times more toxic than AceK per se [68] . Taken together, prudent analyses of the effects of artificial sweeteners in humans and in the environment are crucial in light of their wide-spread use and potential hazard to health. Artificial colors (dyes) are used in many foods including candy, fruit-flavored drinks, many breakfast cereals marketed to children and, not as obviously, in packaged foods containing fruit (e.g., blueberries in blueberry muffins), vitamin supplements, and even white marshmallows. There are nine artificial colors approved for use in the U.S. (see Table 2 ), plus Citrus Red #2, permissible for citrus rinds, and Orange B, allowed in hot dogs and sausage casings. In fact, use of artificial food colors per capita has increased almost fivefold between 1950 and 2010 [69] . This may be important because research has suggested that consumption of artificial colors can reduce attention and increase hyperactivity in sensitive children [69] . However, research correlating artificial color consumption with obesity is scarcer. Amin et al. did not observe an increase in weight gain in rats consuming "low" (15 mg/kg body weight) or "high" (500 mg/kg) concentrations of tartrazine for 30 days [70] , though they did observe alterations in the circulating redox state, which could affect weight gain later in life [71] . Axon et al. discovered that tartrazine and sunset yellow bind the estrogen receptor, thus exhibiting potential to disrupt endocrine function [72] . More investigation into the molecular effects of these compounds, particularly in human cells, is crucial in light of their ubiquity in the food supply, increased consumption, and potential for adverse metabolic effects.
Plastics
Plastics interact with our food supply via numerous points of production, packaging, or transporting. Plastic components (e.g., BPA, phthalates, organotins) leach into food and beverages, especially at high temperatures. Plastic components, along with many pesticides and other persistent organic pollutants (POPs), share a similar mode of action in the etiology of obesity in that they disrupt endocrine communication. Endocrine disrupting compounds (EDCs), by definition, mimic hormones and/or interfere with the production, release, metabolism, or elimination of endogenous hormones. Because many EDCs are lipid soluble, they can accumulate in tissue and thus biomagnify as they traverse the food chain (e.g., humans consume and accumulate compounds that were consumed and accumulated by fish), thereby having enduring effects. Moreover, because of their liberal use, understanding interactions among EDCs is of vital importance in assessing their physiological effects. A recent discussion by Elobeid & Allison concluded that although there is not yet strong evidence in humans that EDCs are contributing to the overweight phenotype, studies in cell culture, animal models, and wildlife as well as epidemiological studies are highly suggestive [34] .
Organotins, organic derivatives of tin, are used liberally for stabilization of plastics [7] . Due to its strong biological effects, the organotin tributyltin inspired the coining of the term "environmental obesogen" [7] . Butyltin compounds have been detected in food containers and parchment paper and are transferred to foods baked in/on these products [73] . Assessment of human exposure to organotins is limited, but significant human exposure is indicated by the presence of organotins in liver, blood, and breast milk ( [7, 73, 74] and references within). Tributyltin, triphenyltin, and, to a lesser extent, dibutyltin, are PPARγ ligands that can induce adipocyte differentiation ( [7] (review) and more recent primary literature [41, [75] [76] [77] ). Prenatal exposure to tributyltin induces increased adiposity in adulthood in mice [7] that results from reprogramming of the differentiation capacity of multipotent mesenchymal stromal cells (MSCs) [78] . The enhanced propensity of MSCs to differentiate into adipocytes induced by tributyltin is inherited transgenerationally in a mouse model [79] .
BPA is one of the highest produced chemicals by volume ( [33, 36] and references within) and is used to make plastic water bottles, line tin cans, and coat production pipes. In humans, it was detected in 95 % of adult urine samples at greater than 0.1 μg/L from an American population ( [34] and references within). Strong positive correlations were revealed between urine BPA concentration and BMI, waist circumference, and high density lipoprotein cholesterol [36] . In vitro and in vivo studies have shown that BPA accelerates adipocyte differentiation and promotes lipid accumulation via alteration of glucose homeostasis as well as by activating the glucocorticoid receptor (review: [34] and publications since then: [80] [81] [82] [83] [84] ). However, not all studies agree that BPA promotes weight gain and adiposity. For example, mouse studies have shown no effect of BPA on weight gain or reduced weight gain following perinatal exposure [34, 83, 85, 86] . Discrepancies among studies may be attributable to differences in sex, estrogen status, species/strain of mouse, dosing timing/ regime, and diet. BPA is known to induce non-monotonic dose responses, thus low dose exposures may be the most relevant to obesogenic endpoints [83] .
Phthalates are used in the pharmaceutical industry, in food production, and in packaging as plasticizing agents. They can be found in the enteric coatings of nutritional and pharmaceutical capsules; polyvinylchloride (PVC) tubing used in food production; packaging of plastic milk cartons, cheese, and meat; and PVC-based plastic wrap [87] . Phthalates, unlike BPA, are not covalently bound to the plastic and thus can readily diffuse into food, especially foods high in fat such as meat due to their high lipophilicity. [89, 90] . Phthalates have been associated with dysregulated sex hormones, obesity, and insulin resistance at a large range of concentrations [4••, 38] . Analysis of data from males in the NHANES study from 1999-2002 revealed significant correlations between four phthalate metabolites and waist circumference and three phthalate metabolites and insulin resistance (review [39] ). Additionally, Trasande et al. reported an association between low molecular weight metabolites of phthalates and increases in being overweight or obese in non-Hispanic black children between the ages of 6-19 years who participated in the NHANES study between 2002-2008 [91] .
Persistent Organic Pollutants (POPs) and Pesticides
POPs are a category of compounds that resist typical chemical, biological, or photolytic degradation. POPs, some of which are used as pesticides, introduce danger because of their stability in the environment; they tend to be hydrophobic and bioaccumulate in the food chain. Some also undergo transformation by natural sunlight irradiation, increasing their toxicity [68] . The 12 POPs of greatest concern, all organochlorides, were addressed in the Stockholm Convention in 2001 and included aldrin, chlordane, dichlorodiphenyltrichloroethane (DDT), dieldrin, dioxins, endrin, furans, heptachlor, hexachlorobenzene, mirex, polychlorinated biphenyls (PCBs), and toxaphene. More recently, chemicals such as perfluorooctanoic acid, organobromines, polybrominated diphenyl ethers, and organotins have been considered POPs as well. Systematic review of the epidemiological data supports an association between POP exposure and type 2 diabetes [8••, 35••] . Also, animal studies with PCBs support the role of these chemicals in modulating glucose/insulin homeostasis. PCB exposure has been shown to impair glucose homeostasis, exacerbate highfat diet-induced insulin resistance, and disrupt lipid metabolism in mice (36 mg Aroclor-1254/kg/wk for 20 wks [44] , 4 × 50 mg PCB-153/kg over 10 wks [46] , 50 mg PCB-77/kg/wk for 2 wks [47] , or 1.6 mg PCB-126/kg/wk for 2 wks [47] ). These few studies likely mark the beginning of a large initiative to document the effects of man-made compounds on the environment and on human health.
Heavy Metals
Inorganic arsenic from natural mineral deposits contaminates drinking water worldwide [92] . As many as 25 million Americas are exposed to concentrations of arsenic in drinking water greater than the Environmental Protection Agency (EPA) drinking water standard of 100 ppb [93] , while people in parts of Bangladesh and Taiwan are exposed to arsenic concentrations >150 ppm [8••] . In addition, because rice is grown in arsenic-contaminated fields, people can be exposed to levels greater than the recommended intake of arsenic by consuming only about ½ cup of rice per day [52] . Inorganic arsenic has been shown to elevate basal glucose and insulin concentrations in rats (1.7 mg arsenite/kg for 90 days), reduce insulin sensitivity in insulin-sensitive cells in cell culture, and, in vitro, interfere with insulin signaling pathways ( [92, 94] and references within). Furthermore, 25 and 50 ppm inorganic arsenic in drinking water for 20 weeks has been shown to exacerbate high-fat diet-induced glucose intolerance in mice [95] . While arsenic exposure has not been linked with accretion of fat mass per se, arsenic indeed impairs adipocyte metabolism in vivo [96] and total arsenic concentration in the urine has been associated with metabolic complications such as type 2 diabetes [8••, 92] .
Cadmium is found in high concentrations in shellfish since it biomagnifies in the aquatic food chain, as well as in the livers of other meat animals. Cadmium can accumulate in other foods, too, as it is present in industrial processes for making plastics. In murine adipocytes, cadmium mimicked the effects of insulin, thus promoting glucose metabolism and lipogenesis [55] . In their review, Edwards and Prozialeck elegantly illustrate a mechanism by which cadmium exposure can lead to elevated blood glucose, diabetes, and diabetic nephropathy [55] . Similar to arsenic, cadmium may not promote adiposity (it may even reduce the size of adipocytes), but it may promote insulin resistance and type 2 diabetes [56] .
Animal Hormones and Milk
Recombinant bovine growth hormone (rbGH; also known as recombinant bovine somatotropin, rbST) was introduced in the 1990s and has increased milk production in cows about 15 % [60] . Despite the amount of press regarding rbGH in relation to obesity and early onset of puberty, the compositions of conventional milk, organic milk, and milk labeled "rbSTfree" are very similar in regard to macronutrient composition and hormone content [61] . In fact, bovine growth hormone is not active in humans, even when injected directly into the bloodstream ( [60] and references within). Thus, it is unlikely that rbGH is contributing to the obesity epidemic directly, but there may be an elusive intermediate factor that has yet to be discovered.
Methods for Identifying Obesogens
The mechanisms by which obesogens can cause weight gain are extremely diverse. Biochemical pathways involving estrogen, testosterone, catecholamines, thyroid hormones, steroids, growth hormone, and endocrine hormones (e.g., insulin, ghrelin, leptin) all influence anabolic and catabolic pathways [6] . In addition, the sympathetic and parasympathetic nervous systems regulate energy metabolism from the level of the brain (e.g., appetite) to the level of the cells (e.g., mobilization of fat stores). The reductionist approach of analyzing individual constituents of the biological system has been successful in identifying molecular targets for several obesogens. However, models developed with this approach are limited in that they cannot accommodate redundant pathways, they do not accurately represent multifarious interactions with a variety of receptors in different tissues, nor do they account for effects that require time to present. Holistic approaches are necessary to complement the reductionist approach in order to observe and understand effects on the entire system.
With the enormous number of potential obesogens that require study, high throughput screening (HTS) methods are necessary. Functional HTS methods are valuable for identifying compounds and also understanding the mechanisms by which the compounds interfere with normal metabolism. Examples of functional HTS screening methods include analysis of glucose output from hepatocytes, insulin secretion from β-cells, and lipid storage/lipolysis in adipocytes. Integrative models that utilize tools from genetics and epigenetics, transcriptomics, proteomics, metabolomics, systems biology, computational biology, and developmental biology are useful to best describe the effects of these compounds on humans without human studies themselves. The establishment of a database will allow pattern recognition and predictions of properties of novel chemicals.
The field of toxicology has been paramount in developing HTS methods and can currently analyze compounds at unprecedented rates. For example, the Tox21 initiative, funded by the United States' EPA, FDA, National Institute of Environmental Health Sciences, and National Institutes of Health Chemical Genomics Center uses a robotic HTS system to evaluate approximately 8000 unique compounds daily for various biological effects. ToxCast™ is an initiative from the EPA to collaborate with Tox21 [97] . Using HTS techniques, compounds can be tested for at least 650 biological effects, and then prioritized for further analysis by other laboratories, including the Endocrine Disruption Screening Program (EDSP) and the drinking water Candidate Contaminant List [98] . The EDSP has been evaluating compounds since 2009 for effects ranging from binding to the estrogen receptor (in silico and in vitro) to the effects on male and female puberty (in vivo, rats). In order to direct efforts toward obesogen identification, the National Toxicology Program enlists experts to identify relevant ToxCast targets for biological processes related to diabetes and obesity (e.g., insulin signaling, islet cell function, adipocyte differentiation, and feeding behavior in Caenorhabditis elegans). Positives and negatives were identified for each pathway from the phase I ToxCast set using the ToxPi analytical prioritization tool [99] . Targeted testing of these putative obesogens is being carried out in relevant biological systems [8••] .
As a new and rigorous in vivo model, zebrafish are an increasingly valuable screening model for the ability of compounds to cause obesity. Zebrafish hold an advantage over cell culture in that they are a complete biological system. Compared to mice, zebrafish experiments can be done more rapidly (11 days vs. about 3 months) and in a much smaller space. Protocols are available for use in screening compounds for their effects on adiposity specifically ([100•] and references within). For example, Lyche et al. introduced female zebrafish to POP mixtures extracted directly from fish in a Norwegian freshwater system [101] . They observed differences in weight gain, age of maturity, and a large spectrum of changes in the transcriptional profile.
In addition to assessing compounds on fat accumulation and metabolism in adults, it is also important to describe the effects of these compounds at sensitive stages in development. Metabolic effects of these compounds have the potential to invoke irreversible damage to prenatal organisms and infants [4••, 102] .
For identifying avenues of future research, epidemiological correlations are extremely valuable [91] . Samples from the U.S. NHANES study have highlighted correlations between various obesogens and increased waist circumference, insulin resistance, low/high birth weights, and other potential associ . However, we must keep in mind the limitations of correlational studies; increased microwave dinners, canned pasta meals, and soda from plastic bottles could increase intake of environmental plastics but the development of the person's obesity may be entirely unrelated to the plastic exposure. In addition, moving forward, a shift from food frequency questionnaires to metabolomics approaches for quantifying food intake will allow a more accurate assessment. Subsequently, additional testing is always essential to differentiate causation from correlation.
What We can Do as Scientists with Identified Obesogens
Once obesogens are identified, we have both responsibilities and opportunities. We have responsibility to inform public policy in order to minimize usage of offensive compounds. Scientists also must develop healthy alternatives to fit the needs of industry and/or antidotes for the offensive compounds. Knowledge of obesogens and their mechanisms will undoubtedly allow a more thorough understanding of the etiology of obesity, which can inform prevention and treatment tactics, including anti-obesity pharmaceuticals. Focusing on these issues will lead to improved efficiency identifying obesogenic compounds and a more streamlined process for safely introducing novel compounds into our food supply. Finally, to prevent unnecessary redundant initiatives, a database should be developed for the tested compounds that do and do not contribute to obesity.
Identification of obesogens is akin to identification of carcinogens in that scientists and clinicians will drive change to provide solutions. In response to the identification of carcinogens, the 1958 Delaney Clause was established to prevent FDA approval of any chemical compound found to cause cancer in animals or humans. Thus, many compounds are already tested for long-term carcinogenic and toxic effects. An additional FDA requirement for reporting body weight increases could help prevent the introduction of future obesogens.
Conclusion
From farm to fork, our food carries thousands of compounds that we consume (Fig. 1) , some of which are harmful and some of which are helpful depending on quantity and context. Photolytic degradation products of compounds [68] as well as bioaccumulation of obesogens from water to crops (e.g., rice), fish, and farm animals [4••] demonstrate that toxicologists and environmental scientists in addition to nutrition and metabolic scientists are crucial in the endeavor to minimize the effects of environmental obesogens. Both holistic and reductionist approaches are needed while heeding physiologically relevant concentrations; zebrafish offer a new, promising model to help reach these goals. In the light of the current obesity epidemic, it is prudent to evaluate everything that is added to our food for potential contributions to obesity. Fig. 1 Compounds are introduced into our food at many stages of the food production process. Waste from factories including persistent organic pollutants (POPs) and heavy metals (e.g., arsenic (As), cadmium (Cd), and lead (Pb)) contaminate the water supply. These compounds can be consumed by fish and then be ingested by humans directly or after further processing. At the farm, these chemicals leach into the crops in the soil, and farmers introduce pesticides to increase crop yield. Animals are fed with antibiotics and hormones (e.g., recombinant bovine growth hormone, rbGH), which have the potential to be transferred to animal products for human consumption. Crops are then refined in order to produce the raw ingredient: insects are removed, organic waste is removed, some products are washed and/or cooked, and solvents are added to wash away chemicals or isolate desired components. At the processing plant, ingredients are combined to produce the final product. Many of the ingredients used in our food supply have not been tested for their effects on key metabolic pathways (see Table 2 ). During processing and packaging, food is exposed to plastic-coated pipes and is packaged into plastic containers or plastic-coated cans. Bisphenol A (BPA) is an example of a compound in plastic that can diffuse into food, especially at high temperatures (e.g., during retorting). Next, preparation of the food, especially during heating, can mobilize chemicals in the packaging (e.g., BPA from baby bottle into milk during microwaving) or the cookware (e.g., perfluorocarbons (PFCs) from non-stick pans [43] ), which can subsequently contaminate the food. Thus, the final food product often contains much more than simply the ingredients added in the large mixer. (Figure courtesy of Ian Robert Kleckner)
